series-c-plus
Stage
1
Investors
About
BrainsGate is an Israeli medical device company that develops neurostimulation therapies for central nervous system diseases. Its primary product is an implantable device designed to treat acute ischemic stroke by electrically stimulating the sphenopalatine ganglion.
Explore BrainsGate's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.